Global Brachytherapy Market To Exceed USD 2199.82 Million By 2035 | CAGR of 7.06%
Category: HealthcareGlobal Brachytherapy Market To Exceed USD 2199.82 Million By 2035
According to a Research Report Published by Spherical Insights & Consulting, the Global Brachytherapy Market Size is Expected to Grow from USD 1038.76 Million in 2024 to USD 2199.82 Million by 2035, at a CAGR of 7.06% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 165 pages with 125 Market data tables and figures & charts from the report on the “Global Brachytherapy Market Size, Share, and COVID-19 Impact Analysis, By Dosage Type (High-Dose Rate (HDR) Brachytherapy and Low-Dose Rate (LDR) Brachytherapy), By Product (Seeds, Applicators & Afterloaders, and Electronic Brachytherapy), By Application (Prostate Cancer, Gynaecological Cancer, Breast Cancer, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/brachytherapy-market
The Brachytherapy Market Size encompasses the use of radiation therapy as a component of specialized cancer care. It involves placing a radioactive source inside or close to the tumor in order to precisely deliver high doses of radiation while preserving nearby healthy tissues. This treatment is commonly used for cancers like skin, breast, prostate, and cervical cancers due to its tailored approach and short treatment duration. The market's size is largely dictated by the prevalence of cancer, advancements in technology, and public knowledge of the benefits of brachytherapy. The market growth is driven by the increased awareness of its therapeutic benefits and the growing global cancer burden, making brachytherapy more and more popular. Through advancements in technology and backing from oncology groups, it is quickly becoming the preferred choice for precise, effective treatment. Brachytherapy's ability to deliver customized radiation with fewer side effects supports its integration into modern cancer care. However, the market growth is hindered by the high setup cost and specialized infrastructure.
The high-dose rate (HDR) brachytherapy segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the dosage type, the brachytherapy market is classified into high-dose rate (HDR) brachytherapy and low-dose rate (LDR) brachytherapy. Among these, the high-dose rate (HDR) brachytherapy segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to the HDR brachytherapy is an outpatient method that can be used either as a treatment in and of itself or after surgery to remove a tumor. One or more sessions of the painless treatment may be required, depending on the type of cancer being treated.
The applicators & afterloaders segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product, the brachytherapy market is divided into seeds, applicators & afterloaders, and electronic brachytherapy. Among these, the applicators & afterloaders segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growth is driven by the applicators’ high preference since they are less invasive and more effective than others. The radioactive sources are transported to the treatment site via a device called an afterloader. During HDR brachytherapy, a single radioactive source is momentarily inserted into the tumor and then taken out.
The prostate cancer segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the application, the brachytherapy market is classified into prostate cancer, gynaecological cancer, breast cancer, and others. Among these, the prostate cancer segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to the many advantages over other types of treatment. Because the radiation dose is delivered precisely, these advantages include a shorter treatment period, a faster recovery, a decreased risk of side effects, an effective treatment for patients with recurrent prostate cancer, and the ability to safely increase the dose to the tumor while minimizing the dose to the surrounding organs, such as the rectum, bladder, and urethra.
North America is anticipated to hold the largest share of the brachytherapy market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the brachytherapy market over the predicted timeframe. The regional growth can be attributed to its many advantages over traditional methods, including improved safety and efficacy of treatment. A suitable reimbursement and regulatory environment also supports regional expansion. Furthermore, because the investment landscape in the region has altered dramatically, businesses are increasingly investing in developing new products and collaborating with emerging companies in an effort to maintain their market share and presence.
Asia Pacific is expected to grow at a rapid CAGR in the brachytherapy market during the forecast period. The region's growth is being driven by the rising rate of illness and the increasing awareness of the target demographic. Additionally, it is expected that the sector would benefit from the introduction of various brachytherapy systems in developing countries like India.
Major vendors in the global brachytherapy market are Varian Medical Systems, Inc., Theragenics Corporation, Becton, CIVCO Medical Solutions, Dickinson & Company, iCAD, Inc., Elekta AB, Eckert & Ziegler BEBIG, Isoray Medical, Inc., IBA, Isoray, Inc., P-Cure Ltd, Panacea Medical Technologies Pvt Ltd., RaySearch Laboratories AB, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In March 2025, BEBIG Medical introduced its innovative SagiNova brachytherapy system at Father Muller Medical College Hospital (FMMCH), coinciding with the opening of a new healthcare wing and the 184th birthday of the hospital's founder. This strategic deployment improves cancer care capabilities at FMMCH by allowing for accurate, high-dose radiation therapy at a lower cost, making cutting-edge treatment more accessible to marginalized people.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the brachytherapy market based on the below-mentioned segments:
Global Brachytherapy Market, By Dosage Type
- High-Dose Rate (HDR) Brachytherapy
- Low-Dose Rate (LDR) Brachytherapy
Global Brachytherapy Market, By Product
- Seeds
- Applicators & Afterloaders
- Electronic Brachytherapy
Global Brachytherapy Market, By Application
- Prostate Cancer
- Gynaecological Cancer
- Breast Cancer
- Others
Global Brachytherapy Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?